Skip to main content
SpringerLink
Log in

Comment on: “Zoo or Savannah? Choice of Training Ground for Evidence-Based Pharmacovigilance”

  • Letter to the Editor
  • Published:
Drug Safety Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Noren GN, Caster O, Juhlin K, Lindquist M. Zoo or savannah? Choice of training ground for evidence-based pharmacovigilance. Drug Saf. 2014;37(9):655–9.

    Article  PubMed  Google Scholar 

  2. Ryan PB, Schuemie MJ, Welebob E, Duke J, Valentine S, Hartzema AG. Defining a reference set to support methodological research in drug safety. Drug Saf. 2013;36(Suppl. 1):S33–47.

    Article  PubMed  Google Scholar 

  3. Coloma PM, Avillach P, Salvo F, et al. A reference standard for evaluation of methods for drug safety signal detection using electronic healthcare record databases. Drug Saf. 2013;36(1):13–23.

    Article  CAS  PubMed  Google Scholar 

  4. Harpaz R, Odgers D, Gaskin G, et al. A time-indexed reference standard of adverse drug reactions. Nat Sci Data 1. 2014. Art ID 140043. doi:10.1038/sdata.2014.43.

  5. Harpaz R, Dumouchel W, Lependu P, Bauer-Mehren A, Ryan P, Shah NH. Performance of pharmacovigilance signal-detection algorithms for the FDA adverse event reporting system. Clin Pharmacol Ther. 2013;93(6):539–46.

    Article  CAS  PubMed  Google Scholar 

  6. Boyce RD, Ryan PB, Noren GN, et al. Bridging islands of information to establish an integrated knowledge base of drugs and health outcomes of interest. Drug Saf. 2014;37(8):557–67.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  7. LePendu P, Iyer SV, Bauer-Mehren A, et al. Pharmacovigilance using clinical notes. Clin Pharmacol Ther. 2013;93(6):547–55.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

Rave Harpaz and Nigam H. Shah acknowledge support by NIH Grant U54-HG004028 for the National Center for Biomedical Ontology and by NIGMS Grant GM101430-01A1.

Competing financial interests

Rave Harpaz, William DuMouchel and Nigam H. Shah declare no competing financial interests. Rave Harpaz and William DuMouchel are employed by Oracle Health Sciences. Nigam H. Shah is a Science Advisor to ApixioInc (http://www.apixio.com), and Kyron Inc (http://www.kyron.com).

Author information

Authors and Affiliations

  1. Oracle Health Sciences, Bedford, MA, USA

    Rave Harpaz & William DuMouchel

  2. Stanford University, Stanford, CA, USA

    Nigam H. Shah

Authors
  1. Rave Harpaz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. William DuMouchel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nigam H. Shah
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rave Harpaz.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Harpaz, R., DuMouchel, W. & Shah, N.H. Comment on: “Zoo or Savannah? Choice of Training Ground for Evidence-Based Pharmacovigilance”. Drug Saf 38, 113–114 (2015). https://doi.org/10.1007/s40264-014-0245-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40264-014-0245-9

Keywords

Search

Navigation